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The use of contraception has afforded many women the opportunity to gain 
control over their reproductive health while also advancing their education and career 
goals. Additionally, hormonal contraceptives have improved women’s quality of life by 
treating and preventing specific clinical symptoms and conditions. Nonetheless, 
disparities and barriers to accessing affordable reproductive care still affect many 
populations of women. This study examines the accessibility and affordability of 
contraception for women’s reproductive and self-care needs, including treating and 
preventing clinical symptoms, conditions, and pregnancy. A literature review of PubMed 
databases was completed for studies in the United States between January 2013 and May 
2021. Studies were chosen based on examining the perceptions, barriers, and advantages 
of acquiring accessible and affordable hormonal contraception on women’s health. 
Though many women benefit from contraceptive use throughout various stages of their 
lives, specific populations of women experience disparities and barriers to accessing 
quality and affordable reproductive care. Many of these barriers include lack of 
knowledge, patient-provider power dynamics, desire for autonomy in one’s reproductive 
health, insurance or cost constraints, and additional policies and actions restricting 
reproductive and contraceptive care availability. Expanding women-focused education, 
services, and policies to address these barriers systematically can improve the 
accessibility and affordability of contraceptive and reproductive care and enhance the 






Women have faced many challenges in accessing quality and affordable health 
care for centuries. Women’s health is defined as the promotion, maintenance, and 
restoration of the physical, psychological, social, and numerous other concerns that affect 
women’s well-being (1). Major issues previously affecting women’s health included 
increased health premiums and denial or lack of coverage for essential services, including 
maternal care, mental health care, and prescriptions for contraceptives (1). The Women’s 
Health Movement sparked initial changes to address the gaps in women’s health by 
providing women control over their reproductive rights, including women as key players 
in clinical research and increasing awareness of the worldwide violence and 
discrimination against women (1). Over the years, federal policies regarding women’s 
health care have shifted. Implementation of the Affordable Care Act in 2014 expanded 
coverage for reproductive-aged women to improve health insurance coverage and limit 
cost-related barriers. Nonetheless, there continue to be prevalent risks to accessing 
quality and affordable preventative and reproductive services for many women.  
Contraception methods have been a critical preventative health service used to 
reduce unintended pregnancies over the years. Contraceptive use has contributed to 
improving women’s self-care and well-being, providing autonomy in making decisions 
about one’s health, and positively impacting families, communities, and society. Types of 
contraceptive methods are divided into hormonal contraceptives and nonhormonal 
contraceptives for protective measures and emergency contraceptives used after sexual 
intercourse. Nonhormonal contraceptives include condoms, vaginal sponges, and 




injectables, categorized as either combined estrogen-progestin or progesterone-only. 
Another method of hormonal contraceptives includes long-acting reversible contraception 
(LARC), which involves hormonal implant devices. The efficacy of these contraceptive 
methods to prevent unintended pregnancies is highest with either the LARC, combined 
estrogen-progestin, or progesterone-only methods (2). The nonhormonal methods are the 
least efficient (2).   
In 2018, more than 99% of sexually active women between the ages of 15 to 44 
reported using some form of contraception in their lifetime (2). Various contraceptive 
methods have contributed to women’s societal advancement by limiting unwanted 
pregnancies while prioritizing their own needs and desires, such as achieving their 
education and career goals. Though contraceptive use has decreased the rates of live 
births, unintended pregnancies, and abortions in the United States, these rates remain 
relatively high compared to similar countries. Significant reproductive health disparities 
are still present among women of color, women with low incomes, and women aged 18 
to 24 (3). These women often face difficulties with the accessibility and affordability of 
quality healthcare. 
Though women have made many improvements historically in the fight for equal 
rights, there are still many restrictions limiting women’s rights to reproductive care. The 
focus of this review is to address the advantages, barriers, constraints, and disparities of 
acquiring accessible and affordable hormonal contraceptives to improve the quality and 






In addition to protecting from unintended pregnancies, hormonal contraceptives 
have been known to treat and prevent gynecological conditions in women. The combined 
estrogen-progestin oral contraceptive pill was initially introduced to treat menstrual 
symptoms, such as migraines, excess menstrual blood loss, dysmenorrhea, and 
premenstrual syndrome (2). Recent studies have found evidence of the treatment of 
various conditions and symptoms specific to women with combined estrogen-progestin 
and LARC methods. These hormonal contraceptives have also been found to treat 
menorrhagia and acne symptoms while also preventing the development of ovarian 
cancer, uterine fibroids, endometriosis, and pelvic inflammatory disease (2).  
However, the need for accessible and affordable hormonal contraceptives for the 
self-care of young women, postpartum women, and perimenopausal women is often 
overlooked. Many young women, including adolescents, experience a high rate of 
unintended pregnancies. The reasons for the high rate of young pregnancies include the 
inability to access effective preventative care, limited disclosure of sexual status, and lack 
of knowledge about reproductive health and contraception options (4). The postpartum 
period is ideal for women to initiate contraception to reduce the risk of short birthing 
intervals, which can cause preterm birth and low birth weights in newborns (5). Many 
women experience changes during the perimenopausal period, including fertility issues, 
urogenital changes, and abnormal bleeding. Contraceptive use during the perimenopausal 
period can relieve these symptoms and treat problems such as loss of bone mineral 




flashes (5). The acquisition and continuation of hormonal contraception have provided 
many benefits to improving women's quality of life and self-care at every stage.  
The knowledge and use of contraceptives give women the power to exert agency 
and advocate for themselves, their future, and their children. Many women have varying 
perceptions and satisfaction of different hormonal contraception methods. A prospective 
cohort study of 5,000 women found 84% satisfied with the LARC method compared to 
53% that used other hormonal contraceptive methods (6). Factors that influence women’s 
satisfaction include ease of use, improvements in bleeding and cramping patterns, 
perceived effectiveness, and limited side effects (6). However, a large proportion of 
women have negative perceptions of hormonal contraception. The most influencing 
factors contributing to women’s negative perception of hormonal contraception are cost, 
provider bias, lack of provider knowledge or training, and accessibility barriers (7).   
Barriers to Affordable and Accessible Contraception for Women 
Healthcare providers play an essential role in educating and promoting the health 
benefits of contraceptive care while enabling open, patient-centered communication 
concerning the unique demands of each woman’s health. Unfortunately, many women’s 
misperceptions and unfounded concerns surrounding hormonal contraceptive use are 
often enabled by their healthcare providers’ lack of knowledge about the various 
methods. Many women prefer to use family planning services that offered LARC 
methods compared to other hormonal contraceptives (8). Notably, the LARC method has 
the highest satisfaction and effectiveness of use. Still, barriers such as provider 




insertion for postpartum women have affected their continuation of use (9).  Though 88% 
of physicians report providing long-acting hormonal contraceptives, 24% of internal 
medicine or pediatric physicians also prescribe and provide these methods (9).  This may 
be due to the long-term cost of LARC methods being lower than the long-term cost of 
monthly refills for pills, patches, or injectables. However, the upfront cost of LARC 
methods is more costly than other hormonal contraceptive methods (9). Primary care 
physicians are the first-line providers for many women as compared to obstetrician-
gynecologist. However, very few residency programs adequately train students of 
different specialties in counseling, prescribing, and providing hormonal contraceptives 
(2). A primary care physician will often refer a patient to an obstetrician-gynecologist to 
provide contraception counseling or insert a contraceptive device. It would be beneficial 
to patients to have primary care specialists also educated, trained and confident in 
counseling women on reproductive health and contraceptive options, following the 
guidance of the CDC’s Medical Eligibility Criteria (2).  
Significant barriers obstruct the affordability and accessibility of effective 
women’s reproductive healthcare and contraceptive acquisition.  In 2014, the Affordable 
Care Act required all private insurance plans to cover all FDA-approved hormonal 
contraceptive methods with no out-of-pocket costs. The expansion of Medicaid and 
private insurance decreased the proportion of uninsured women from 18.9% in 2012 to 
11.5% in 2015, with little to no changes today (10; 11). Despite the Affordable Care 
Act’s influence to reduce disparities in women’s health coverage by expanding Medicaid 
and private coverage for women of reproductive age, costs of hormonal contraception for 




all approved contraceptive methods, coverage varies depending on state and insurer.  
Insurance barriers, such as a lack of coverage, cost-sharing, and limiting the number of 
products dispersed at a time, cause significant constraints and often lead to 
discontinuation of hormonal contraceptive use (12). The American College of 
Obstetricians and Gynecologists recommends that payment policies support providing 3-
13 month supplies of oral contraceptives to maintain the individual continuation of use 
(12).  These barriers pose a challenge to many women as it may become difficult to 
maintain routine administration or demanding to access a provider to get a new 
prescription.   
Additionally, cost-sharing varies between insurance coverage plans. Individual 
plans with high out-of-pocket costs, deductibles, and copayments can be barriers to 
accessing and maintaining contraceptive services. Previous findings suggest lower cost-
sharing can increase the use of effective contraceptive methods (13). Even with 
reproductive care covered by publicly and privately owned insurance plans, women still 
pay 60% out-of-pocket costs for contraception methods compared to 33% for non-
contraceptive drugs (12).  
 Though the Accessible Care Act of 2014 increased insurance coverage for 
women’s health and preventative care, women saw little to no change in their ability to 
access care. Several structural barriers limit women’s accessibility to contraceptive care. 
Contraceptive services often require an annual physician visit to be screened, counseled, 
get a prescription, then obtain the chosen contraceptive method, frequently from a 
pharmacy. The requirement for annual medical screenings and multiple provider visits is 




policies (12).  Though physician screenings and counseling are beneficial to assist 
individuals in making the best decision to initiate contraceptive use depending on their 
health status, annual pelvic examinations and cervical cytology can discourage a woman 
from continuing the use of a particular method. Some providers also refuse same-day 
services for contraceptives, such as LARC and other hormonal methods, to acquire a 
pregnancy test before inserting the implant device. However, there are instances in which 
a pregnancy test is not needed, such as when the last menstruation was less than seven 
days ago or if a patient has not had unprotected sex since the last menstrual cycle (9). 
Additionally, inconvenient office hours, a limited range of method knowledge, and 
availability also pose a challenge for women accessing or continuing contraceptive care. 
Expanding women’s access to reproductive and contraceptive care by removing the 
financial and structural barriers to access providers and clinics should continue to be an 
important goal of women’s health while also ensuring women’s preferences and desires 
are the focus. 
Additionally, federal, state, and local restrictive policies and legislature interfere 
with the provision and coverage surrounding the accessibility and affordability of 
contraception and reproductive services. The Affordable Care Act of 2014 aimed to 
improved coverage for essential women’s health services; however, specific coverage 
exclusions continue to prevent women from receiving quality and affordable preventative 
and reproductive services (14).  In 2018, Trump also released two rulings allowing 
exemptions for employees in covering women’s contraceptive care due to religious 
beliefs or nonreligious moral objections (15). These unfavorable rulings act to interfere 




Minors are currently restricted in 20 states from acquiring contraceptive services even 
with parental consent (12). Conversely, the American College of Obstetricians and 
Gynecologists recommends and supports accessible and affordable women’s health and 





A literature review of the PubMed database was conducted to review articles and 
studies in the United States between January 2013 to May 2021. The studies sampled or 
examined experiences of reproductive-aged women 15 to 44 years old. Studies were 
chosen based on examining the benefits, perceptions, difficulties, and challenges 
affecting the accessibility and affordability of women’s reproductive health regarding 
acquiring hormonal contraceptives. To select studies, a keyword search, with Boolean 
phrases AND/OR, was used involving the following terms: female, women, women’s 
health, contraception, contraceptives, health care, preventative care, women’s self-care, 
self-care, access, accessibility, hormonal contraception, reproductive health, health 
service, reproductive health service, women’s health care, affordability, cost, women’s 
preventative care, insurance barriers, insurance constraints, policies, laws, Affordable 
Care Act. Additional phrases searched included: challenges in access, barriers in access, 
improvements in access, challenges in affordability, barriers in affordability, 
improvements in affordability, challenges in cost, barriers in cost, improvements in cost. 
No hard copy journal searches were conducted. Criteria for inclusion included women of 
reproductive age, a focus on women’s health beyond protecting from unintended 
pregnancies, and facilitating or limiting factors affecting accessible and affordable 
acquisition of contraceptives for women’s self-care and reproductive health. Recent 
advancements and innovations to accessing affordable contraceptive care were also 






The affordability and accessibility of health services for women’s reproductive 
health and self-care have progressed over the years. Nonetheless, many improvements are 
still necessary. The implementation of the Affordable Care Act of 2014 expanded 
coverage for women’s preventative health services, which included contraceptive 
counseling and care. Unfortunately, many women still deal with increased out-of-pocket 
spending, cost-sharing effects, and obstacles to accessing reproductive health services. 
There is also a need to improve provider knowledge deficits to counsel women in 
choosing a safe contraceptive method under the U.S. Medical Eligibility Criteria for 
Contraceptive Use guidelines. Obstetrician gynecologists, internal medicine providers, 
and pediatricians can be strong advocates for safe, affordable contraceptive access. As 
women require different health resources throughout their lifetime to maintain power 
over their health and lives, open, patient-centered communication and care should be 
supported to enable women to make informed choices about their reproductive and self-
care health maintenance. 
To Improve the Affordability of Hormonal Contraceptives 
 The expansion of insurance plans to cover all FDA-approved contraceptive 
methods may have assisted in coverage for many women’s preventative care services; 
however, out-of-pocket costs did not change.  Privately insured women saw an increase 
in out-of-pocket expenses due to cost-sharing effects (13). In contrast, publicly insured 
women, such as those under Medicaid, saw decreased out-of-pocket costs (13). Women 




increased out-of-pocket costs is another way to limit the power women have over their 
health. Though the Affordable Care Act seemed effective in transferring some of the cost 
burdens away from women, it may be a while before cost-sharing is eliminated.  
 Studies have shown women, insured and uninsured, still face burdens being able 
to afford specialist care, prescription medications, screenings, multiple visits, and annual 
STD and pelvic examinations (16).  Health policies, organizations, and insurance 
companies should eliminate cost-sharing to obtain women’s reproductive and self-care 
services. Diminishing cost-sharing has the potential to lead to increased contraceptive 
continuation. A lower out-of-pocket cost may also be the difference between choosing a 
contraceptive method over another and considering personal lifestyle and health status.  
Diminishing copayments, high deductibles, and coinsurance for comprehensive 
contraceptive services and prescriptions may increase adherence to contraceptive use for 
women’s reproductive and self-care maintenance.  
To Improve the Accessibility of Hormonal Contraceptives 
 Expanded access to affordable preventative care has contributed to many benefits 
for women’s health; however, threats to comprehensive reproductive services still exist. 
In 2020, there was an increase in women who saw or talked to a physician in the past 12 
months (16). Nonetheless, gaps in access to quality reproductive care are still a barrier to 
overcome. Providers should be educated in counseling, prescribing, and providing 
contraceptive options to women of all ages. There should be increased access to newer, 
safer formulations for oral contraceptive methods and an increase in the availability of 




LARC methods without regard to their personal health histories or status (17). Physician 
training programs and organizations should aim to overcome provider bias in the 
counseling and providing of hormonal contraceptives and instead consider individual 
women’s unique health needs and desires for reproductive and self-care.  
 Access to contraception should be universally unrestricted by the government to 
improve the quality of life for women throughout their lifespan. New legislation, enacted 
in 2017, has expanded access to contraception in 22 states plus Washington, D.C., to 
provide a year-long supply of all forms of self-administered hormonal contraceptive 
methods (18). This law aimed to increase method continuation, including the provision 
and use of combined and progestin-only oral contraceptive pills, the vaginal ring, and the 
patch (18). There remain obstacles in the full implementation of this law, such as store 
policies and insurance reimbursement challenges, that must be addressed. Patients, 
providers, and prescribers must be informed of this new law to advocate for the 
development of new protocols and personnel training in pharmacies and insurance 
companies  (18). Overall, all women have the right to affordable and accessible health 
services without restriction from the government or insurance companies for self-care 
and reproductive health throughout various stages of their life span to maintain optimal 





RECOMMENDATIONS FOR FUTURE STUDIES 
 Future studies should take into account the deficits in research considering 
expanding access to adolescents, strengthening insurance coverage, access and 
affordability, and the implications of recent innovations on these factors. Expanding 
access to hormonal contraceptives for adolescents holds many benefits. Adolescents are 
often overlooked in research and policy implementation surrounding hormonal 
contraceptive use. Minors should be included in the research, design, and implementation 
of expanded hormonal contraceptive options (4). Additionally, advocacy to expand 
adolescent access to hormonal contraceptives is necessary if increased access 
significantly benefits this population.  
The effects of the Affordable Care Act related to coverage, access, and 
affordability of comprehensive women’s reproductive health are also critical. There are 
many gaps in research regarding the continuation of services for minority communities, 
the impact of eliminating cost-sharing, and patient-focused outcomes.  There is also a 
need to assess the impact of the Affordable Care Act’s expansion on contraceptive brand 
use. Because the Act does not mandate insurance companies cover all contraception 
brands, the choice of a brand could determine an individual’s out-of-pocket cost for 
services (13).  An analysis on subgroups that experience the most disparities in care and a 
comparison analysis of private insurers to public insurers concerning contraceptive use 
and continuation patterns is also lacking in research (16). Overall, improvements in the 
policies and stability of insurance plans by expanding Medicaid in all states and 
maintaining the Marketplace supports strengthening the accessibility and affordability of 




Additionally, a debate to implement new methods to expand affordable and 
accessible contraceptive care has been discussed. Several innovations to increase 
contraceptive access for women of all ages are being developed, such as over-the-counter 
oral contraceptives, pharmacist prescribing, and web-based telehealth platforms (4). 
State-to-state variability in insurance plans, pharmacy prescribing, and telehealth laws are 
just some barriers to implementing these innovations to accessible contraceptive care. 
Many measures must be considered before implementation of over-the-counter 
access to hormonal contraception begins. Products dispensed over-the-counter must have 
a low potential for misuse and abuse and limit the potential consequences for 
inappropriate self-selection. Over-the-counter access will likely begin with progestin-
only pills, not combined oral contraceptives, due to their safety and low side effects 
profile (4).  There is currently a lack of legislative mandates, policies, and financial 
incentives for insurance companies to implement over-the-counter access to hormonal 
contraceptives (19). There is also concern that this method may reduce the need for 
routine preventative screenings, such as pap smears, pelvic exams, breast exams, and 
sexually transmitted infections and disease screenings (20). Though adolescents are in 
support of over-the-counter access, many adults oppose this option for minors.  
In the past five years, there has been an expansion in state legislature allowing 
pharmacists to prescribe hormonal contraceptives (4). This innovation allows for 
increased access to contraceptive services with pharmacists counseling, screening for 
contraindications, and prescribing an appropriate hormonal contraceptive method for use. 
This method is also not supported for adolescent access, as adolescents tend to over-




enactment of this innovation. They include a lack of standard protocols, a negative 
impact on pharmacy workflow, and patient materials not suitable for minors (21). 
Additional threats include the requirement for a different skill set compared to a 
traditional pharmacist and an inability to provide private counseling due to limited space. 
One method to overcome these barriers is the use of collaborative drug therapy 
management. This program involves a collaborative agreement between physicians and 
pharmacists granting pharmacists professional responsibility for many roles (4). Further 
studies involving this method may prove beneficial to increasing access and continuation 
of hormonal contraceptive methods.  
Laws regarding what services can be accessed through telehealth services also 
varies from state to state. Telehealth services have the ability to increase access to 
women’s reproductive health and contraceptive services. Women of all ages are able to 
safely be screened and consulted by a physician before being prescribed a particular 
contraceptive method for use (4). Many companies and health organizations currently 
provide telehealth services for prescription hormonal contraceptives. Significant reasons 
for promoting telehealth expansion for contraceptive and women’s health services 
include ease of online service, inability to get an appointment with a provider, and a need 
for confidentiality.  
Overall, women face many obstacles in obtaining affordable and accessible 
contraception for women’s reproductive and self-care needs. Structural barriers, coverage 
barriers, and political barriers limit women’s ability to have power and autonomy over 
their health achieving future goals. Reducing the barriers to affordable and accessible 




ability to improve women’s confidence in initiating and continuing the use of hormonal 
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